Catalyst Bioventures LLC is categorized under Research and Development Laboratories in Temple, TX and active since 2010.
Catalyst Bioventures LLC was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Chris Thornton at the company’s single location by writing to 3000 South 31st St # 408, Temple, Texas TX 76502 or by phoning (254) 624-5747. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Catalyst Bioventures LLC |
| Contact Person: | Chris Thornton |
| Address: | 3000 South 31st St # 408, Temple, Texas 76502 |
| Phone Number: | (254) 624-5747 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Catalyst Bioventures LLC was started in 2010 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Chris Thornton for inquiries that concern Catalyst Bioventures LLC by calling the company number (254) 624-5747, as your correspondence is most welcome. Additionally, the physical location of the single location of Catalyst Bioventures LLC can be found at the coordinates 31.071481,-97.368887 as well as the street address 3000 South 31st St # 408 in Temple, Texas 76502.
For its online presence, you may visit Catalyst Bioventures LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.